Short Interest in Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Decreases By 28.6%

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the recipient of a significant drop in short interest during the month of November. As of November 15th, there was short interest totalling 500 shares, a drop of 28.6% from the October 31st total of 700 shares. Based on an average daily trading volume, of 12,800 shares, the short-interest ratio is presently 0.0 days.

Relief Therapeutics Price Performance

Shares of RLFTF stock traded up $0.02 during mid-day trading on Friday, hitting $5.60. The company had a trading volume of 327 shares, compared to its average volume of 2,846. The stock’s 50 day moving average price is $5.64 and its 200-day moving average price is $2.96. Relief Therapeutics has a 52-week low of $1.10 and a 52-week high of $7.66.

About Relief Therapeutics

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.